122 related articles for article (PubMed ID: 8908949)
1. The use of transrectal ultrasound placement of radioactive seeds for the definitive treatment of prostate cancer.
Zachow SE; Hargis R
J Miss State Med Assoc; 1996 Oct; 37(10):771-5. PubMed ID: 8908949
[TBL] [Abstract][Full Text] [Related]
2. Evolution of techniques for ultrasound-guided palladium 103 brachytherapy in 950 patients with prostate cancer.
Sharkey J; Chovnick SD; Behar RJ; Perez R; Otheguy J; Rabinowitz R; Solc Z; Huff W; Cantor A; Steele J; Webster C; Donohue M
Tech Urol; 2000 Jun; 6(2):128-34. PubMed ID: 10798814
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate.
Stone NN; Ramin SA; Wesson MF; Stock R; Unger P; Klein G
J Urol; 1995 May; 153(5):1555-60. PubMed ID: 7536266
[TBL] [Abstract][Full Text] [Related]
4. Transrectal ultrasound-guided interstitial radiation therapy for localized prostate cancer.
Brosman SA; Tokita K
Prog Clin Biol Res; 1991; 370():291-300. PubMed ID: 1924462
[No Abstract] [Full Text] [Related]
5. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
6. The role of brachytherapy in the definitive management of prostate cancer.
Crook J
Cancer Radiother; 2011 Jun; 15(3):230-7. PubMed ID: 21514199
[TBL] [Abstract][Full Text] [Related]
7. The current role of imaging for prostate brachytherapy.
Carey B; Swift S
Cancer Imaging; 2007 Feb; 7(1):27-33. PubMed ID: 17339141
[TBL] [Abstract][Full Text] [Related]
8. Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants.
Dawson JE; Wu T; Roy T; Gu JY; Kim H
Radiother Oncol; 1994 Sep; 32(3):268-70. PubMed ID: 7816946
[TBL] [Abstract][Full Text] [Related]
9. A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.
Heysek RV; Gwede CK; Torres-Roca J; Cantor A; Kelley S; Saini AS; Pow-Sang J
Brachytherapy; 2006; 5(4):244-50. PubMed ID: 17118318
[TBL] [Abstract][Full Text] [Related]
10. Transrectal ultrasound-guided interstitial radiation therapy for localized prostate cancer.
Brosman SA; Tokita K
Urology; 1991 Oct; 38(4):372-6. PubMed ID: 1721754
[TBL] [Abstract][Full Text] [Related]
11. Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis.
Merrick GS; Butler WM; Dorsey AT; Walbert HL
Radiat Oncol Investig; 1997; 5(6):305-13. PubMed ID: 9436248
[TBL] [Abstract][Full Text] [Related]
12. [Technique of intraoperative planning in prostatic brachytherapy with permanent implants of 125I or 103Pd].
Prada Gómez PJ; Juan Rijo G; Hevia Suarez M; Abascal García JM; Abascal García R
Arch Esp Urol; 2002 Dec; 55(10):1217-23; discussion 1223-4. PubMed ID: 12611219
[TBL] [Abstract][Full Text] [Related]
13. Radioactive "seed" implants may rival surgery for low-risk prostate cancer patients.
Hede K
J Natl Cancer Inst; 2007 Oct; 99(20):1507-9. PubMed ID: 17925531
[No Abstract] [Full Text] [Related]
14. Iodine 125 brachytherapy for early stage prostate cancer: new techniques may achieve better results.
Wallner K
Oncology (Williston Park); 1991 Oct; 5(10):115-22; discussion 122, 125-6. PubMed ID: 1838264
[TBL] [Abstract][Full Text] [Related]
15. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
International Commission on Radiological Protection
Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
[TBL] [Abstract][Full Text] [Related]
16. Prostate implant therapy: iodine-125 versus palladium-103.
Peschel RE
Cancer J; 2005; 11(5):383-4. PubMed ID: 16259868
[No Abstract] [Full Text] [Related]
17. Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator.
Kunos CA; Resnick MI; Kinsella TJ; Ellis RJ
Brachytherapy; 2004; 3(2):71-7. PubMed ID: 15374538
[TBL] [Abstract][Full Text] [Related]
18. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Walbert HL
Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative segmentation of iodine and palladium radioactive sources in C-arm images.
Amat di San Filippo C; Fichtinger G; Morris WJ; Salcudean SE; Dehghan E; Fallavollita P
Int J Comput Assist Radiol Surg; 2014 Sep; 9(5):769-76. PubMed ID: 24504857
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of prostate cancer brachytherapy].
Hannoun-Levi JM; Chevallier D; Cosset JM; Gerbaulet A
Bull Cancer; 2012 Dec; 99(12):1175-81. PubMed ID: 23228827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
